0001640455-18-000012.txt : 20180205
0001640455-18-000012.hdr.sgml : 20180205
20180205180455
ACCESSION NUMBER: 0001640455-18-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180201
FILED AS OF DATE: 20180205
DATE AS OF CHANGE: 20180205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole Hugh M
CENTRAL INDEX KEY: 0001604646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 18575541
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_151787188099200.xml
FORM 4
X0306
4
2018-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001604646
Cole Hugh M
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Business Officer
Stock Option (Right to Buy)
23.98
2018-02-01
4
A
0
70500
0
A
2028-02-01
Common Stock
70500.0
70500
D
The option will vest quarterly in 16 equal installments following January 1, 2018.
/s/ Anna L. Barry, Attorney-in-Fact
2018-02-05